RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding RAPT Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 99 | 85 | −14 |
| Shares | 27.8M | 28.0M | +181.3K (+0.7%) |
| Value | $1.02B | $616.1M | −$403.9M (−39.6%) |
New holders (10)
Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Redmile Group, LLC | 748,677 | $16.5M | 0.51% |
| Woodline Partners LP | 358,443 | $7.88M | 0.13% |
| Candriam Luxembourg S.C.A. | 157,764 | $3.47M | 0.02% |
| Citadel Advisors LLC | 73,318 | $1.61M | 0.00% |
| Barclays PLC | 26,370 | $580.0K | 0.00% |
| Amalgamated Bank | 3,469 | $76.0K | 0.00% |
| Amalgamated Financial Corp. | 3,469 | $76.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 859 | $19.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 12 | $0 | 0.00% |
| Covestor Ltd | 9 | $0 | 0.00% |
Sold out (24)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.